This report specifies the importance of Stem Cell Research in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other). Projections and estimates are graphically illustrated by geographic region encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 23 major companies are discussed in the report. The report serves as a guide to global market for Stem Cell Research in Cardiology covering 229 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Exhibits (27) complement the text.

Free Sample Research Report

Download Table of contents

Heart disease has assumed great magnitude as an endemic health problem. Cardiology field has seen significant efforts in clinical research in the past few years with the development of new drugs and surgical modalities of therapy as well. However, the mortality rates remain very high. In this context, stem cell applications in cardiology assume great significance since stem cells have been found to be successfully used in tissue regeneration. Heart disease, including myocardial infarction and ischemia, can be treated with the applications of stem cells.

The concept of stem cell transplantation to regenerate the myocardium and better the working of the heart has received a great deal of attention in recent times. Small-scale studies in the pre-clinical and clinical stages support the use of stem cells in treating heart disease. However similar such studies must be carried out on a larger-scale to corroborate the findings and prove stem cell therapy as a viable alternative method of treating patients with heart disease.

The global market for Stem Cells in Cardiology is projected to reach about US$ 3.5 billion by 2012. Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. Embryonic stem cells to treat cardiac disorders is a very interesting area of research. However, due to various ethical issues, this area is mired in debates all over the world.

Aldagen, Inc. (USA)
Athersys, Inc. (USA)
Axordia Ltd. (UK)
Baxter International (USA)
Bioheart, Inc. (USA)
Cellartis AB (Sweden)
CellSeed, Inc. (Japan)
Cellular Dynamics International, Inc. (USA)
Cytori Therapeutics, Inc. (USA)
Gamida Cell Ltd. (Israel)
Geron Corporation (USA)
MaxCyte, Inc. (USA)
NovaThera Ltd. (UK)
Osiris Therapeutics, Inc. (USA)
PrimeGen Biotech LLC (USA)
Regenocyte Therapeutic (USA)
Reliance Life Sciences (India)
RNL BIO Co., Ltd. (South Korea)
Stempeutics Research Pvt. Ltd. (India)
TheraVitae Co., Ltd. (Thailand)
ViaCord (USA)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	Provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the global market of Stem Cell Research in Cardiology. List of Global major companies in also included in this chapter.	$1300
III	Product / Technology Research	This chapter gives an insight into Stem Cell Research market including definitions, segmentation and applications. The chapter also provides market values in US$ (for the period 2005 through 2012) by source and by type for stem cell applications in Cardiology.	$1100
IV	Market Dynamics	Market Dynamics provides information on global markets for Stem Cell Research in Cardiology. The chapter includes global market analysis by geographic regions a brief business profile of major global companies; and a glance at corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc.	$1600
V	Corporate Directory	This chapter provides the region-wise list of 229 companies, CROs, and academic institutions that are engaged in Stem Cell Research in Cardiology products and services.	$300